Rosiglitazone, an agonist of peroxisome proliferator-activated receptor-gamma, prevents contralateral testicular ischaemia-reperfusion injury in prepubertal rats

INAN, Mustafa; BASARAN, Umit; DOKMECI, Dikmen; KANTER, Mehmet; YALCIN, Omer; Aydogdu, NURETTİN; TURAN, Nesrin

doi:10.1111/j.1440-1681.2007.04594.x

Rosiglitazone, an agonist of peroxisome proliferator-activated receptor-gamma, prevents contralateral testicular ischaemia-reperfusion injury in prepubertal rats

INAN M., BASARAN U., DOKMECI D., KANTER M., YALCIN O., Aydogdu N., ...Daha Fazla

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, cilt.34, ss.457-461, 2007 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 34
Basım Tarihi: 2007
Doi Numarası: 10.1111/j.1440-1681.2007.04594.x
Dergi Adı: CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.457-461
İnönü Üniversitesi Adresli: Hayır

Özet

1. Rosiglitazone plays a positive role in the reparation of ischaemia-reperfusion (I/R) injury in different tissues. Thus, we examined its biochemical and histological effects on the contralateral testes to determine whether exogenous rosiglitazone affords any protection against testicular damage.